Cited by 160Immune Response and InflammationCell death mechanisms and regulationImmunotherapy and Immune Responses

Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- -dependent mechanism

Paone, A., Starace, D., Galli, R., Padula, F., De Cesaris, P., Filippini, A., Ziparo, E., Riccioli, A.·2008·Carcinogenesis

Abstract

Toll-like receptors (TLRs) are known to play a key role in the innate immune system particularly in inflammatory response against invading pathogens. Recent reports strongly indicate that they play important roles in cancer cells. Prostate cancer represents one of the most common cancer for which no cure is available once metastatic and androgen refractory. Since TLR3 has been recently suggested as a possible therapeutic target in some cancer cell lines, we studied TLR3 expression and functionality in two human prostate cancer cell lines, LNCaP and PC3. We report that both cell lines express TLR3 and that the TLR3 agonist poly (I:C) activates mitogen-activated protein kinases and induces inhibition of proliferation as well as caspase-dependent apoptosis. By using pharmacological and genetic approaches, we demonstrate the involvement of TLR3 in poly (I:C)-induced effects. We also show that a novel interferon-independent pathway involving protein kinase C (PKC)-alpha activation, upstream of p38 and c-jun N-terminal kinase, is responsible for poly (I:C) pro-apoptotic effects on LNCaP cells. To our knowledge, this is the first report describing a role of PKC-alpha in poly (I:C)-mediated apoptosis. The comprehension of the mechanisms underlying TLR3-mediated apoptosis can contribute tools to develop new agonists useful for the treatment of prostate cancer.

Integrity signals

Registry

Crossref · 10.1093/carcin/bgn149

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TLR3 can directly trigger apoptosis in human cancer cells in response to poly(I:C).

    “TLR3 can directly trigger apoptosis in human cancer cells in response to the double-strand RNA synthetic agonist polyinosinic-polycytidylic acid (poly(I:C)) [28, 29], which is a mimic for viral double-stranded RNA that triggers an innate immune response following viral infection.”
  • Poly(I:C) treatment induced TLR3 dependent apoptosis in human prostate cancer cells.

    “Paone et al., [28] showed that poly(I:C) treatment induced TLR3 dependent apoptosis in human prostate cancer cells.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Paone, A., Starace, D., Galli, R., Padula, F., De Cesaris, P., Filippini, A., Ziparo, E., & Riccioli, A.
Affiliations
Istituto Pasteur (IT)
Venue
Carcinogenesis
Published
2008-05-29
Volume
29
Issue
7
Pages
1334-1342
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2125840697
Cited by
160
References
2
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 10 · 2018: 4 · 2017: 10 · 2016: 5 · 2015: 11 · 2014: 10 · 2013: 18 · 2012: 19
FWCI
5.03
Type
journal article
Language
en
Open access
closed
Locations
  • Carcinogenesis (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
TLR3, prostate cancer, apoptosis, protein kinase C alpha, poly(I:C), p38 MAPK, c-Jun N-terminal kinase, caspase-dependent apoptosis, LNCaP cells, PC-3 cells, TLR3 agonist, cancer immunotherapy
MeSH terms
Enzyme Activation, Humans, Male, Phosphorylation, Poly I-C, Prostatic Neoplasms, Receptors, Androgen, Transfection, Tumor Suppressor Protein p53, Interferon-beta, Apoptosis, Mitogen-Activated Protein Kinases, Cell Line, Tumor, p38 Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Cell Growth Processes, Toll-Like Receptor 3, Protein Kinase C-alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review